Community-based, point-of-care hepatitis C testing

perspectives and preferences of people who inject drugs

Ned H. Latham, Alisa Pedrana, Joseph S. Doyle, Jessica Howell, Bridget Williams, Peter Higgs, Alexander J. Thompson, Margaret E. Hellard

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

A barrier to hepatitis C treatment for people who inject drugs (PWID) is needing to attend multiple appointments for diagnosis. Point-of-care hepatitis C tests provide results within 20 to 105 minutes and can be offered opportunistically in nonclinical settings such as needle syringe programmes. In this nested qualitative study, we explored the acceptability of point-of-care testing for PWID. PWID attending participating needle syringe programmes were screened using the OraQuick HCV antibody mouth swab (result in 20 minutes); those with a reactive result then underwent venepuncture for a point-of-care RNA test: the Xpert HCV Viral Load (result in 105 minutes). Convenience sampling was used to select participants for a semi-structured interview. A hybrid thematic analysis was performed, guided by Sekhon's “Theoretical Framework of Acceptability.” Nineteen participants were interviewed. Three core themes emerged: "people and place," "method of specimen collection," and "rapidity of result return." It was highly acceptable to be offered testing at the needle syringeprogrammes by nurses and community health workers, who were described as competent and nonjudgemental. Most participants reported that even if a finger-stick point-of-care RNA test were an option in the future, they would prefer venepuncture, as the sample could be used for pre-treatment workup and bundled testing. Waiting 20 minutes to receive the antibody test result was acceptable, whereas the 105 minutes required for the RNA result was unacceptable. Offering point-of-care hepatitis C testing at needle syringe programmes is acceptable to PWID, however tests that avoid venepuncture are not necessarily the most attractive to PWID.

Original languageEnglish
Pages (from-to)919-922
Number of pages4
JournalJournal of Viral Hepatitis
Volume26
Issue number7
DOIs
Publication statusPublished - Jul 2019

Keywords

  • Community Health Services
  • hepatitis C
  • needle-exchange programs
  • point-of-care systems
  • substance abuse, intravenous

Cite this

@article{52d76f64d3ee44228cc5da3e324d2683,
title = "Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugs",
abstract = "A barrier to hepatitis C treatment for people who inject drugs (PWID) is needing to attend multiple appointments for diagnosis. Point-of-care hepatitis C tests provide results within 20 to 105 minutes and can be offered opportunistically in nonclinical settings such as needle syringe programmes. In this nested qualitative study, we explored the acceptability of point-of-care testing for PWID. PWID attending participating needle syringe programmes were screened using the OraQuick HCV antibody mouth swab (result in 20 minutes); those with a reactive result then underwent venepuncture for a point-of-care RNA test: the Xpert HCV Viral Load (result in 105 minutes). Convenience sampling was used to select participants for a semi-structured interview. A hybrid thematic analysis was performed, guided by Sekhon's “Theoretical Framework of Acceptability.” Nineteen participants were interviewed. Three core themes emerged: {"}people and place,{"} {"}method of specimen collection,{"} and {"}rapidity of result return.{"} It was highly acceptable to be offered testing at the needle syringeprogrammes by nurses and community health workers, who were described as competent and nonjudgemental. Most participants reported that even if a finger-stick point-of-care RNA test were an option in the future, they would prefer venepuncture, as the sample could be used for pre-treatment workup and bundled testing. Waiting 20 minutes to receive the antibody test result was acceptable, whereas the 105 minutes required for the RNA result was unacceptable. Offering point-of-care hepatitis C testing at needle syringe programmes is acceptable to PWID, however tests that avoid venepuncture are not necessarily the most attractive to PWID.",
keywords = "Community Health Services, hepatitis C, needle-exchange programs, point-of-care systems, substance abuse, intravenous",
author = "Latham, {Ned H.} and Alisa Pedrana and Doyle, {Joseph S.} and Jessica Howell and Bridget Williams and Peter Higgs and Thompson, {Alexander J.} and Hellard, {Margaret E.}",
year = "2019",
month = "7",
doi = "10.1111/jvh.13087",
language = "English",
volume = "26",
pages = "919--922",
journal = "Journal of Viral Hepatitis",
issn = "1352-0504",
publisher = "Wiley-Blackwell",
number = "7",

}

Community-based, point-of-care hepatitis C testing : perspectives and preferences of people who inject drugs. / Latham, Ned H.; Pedrana, Alisa; Doyle, Joseph S.; Howell, Jessica; Williams, Bridget; Higgs, Peter; Thompson, Alexander J.; Hellard, Margaret E.

In: Journal of Viral Hepatitis, Vol. 26, No. 7, 07.2019, p. 919-922.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Community-based, point-of-care hepatitis C testing

T2 - perspectives and preferences of people who inject drugs

AU - Latham, Ned H.

AU - Pedrana, Alisa

AU - Doyle, Joseph S.

AU - Howell, Jessica

AU - Williams, Bridget

AU - Higgs, Peter

AU - Thompson, Alexander J.

AU - Hellard, Margaret E.

PY - 2019/7

Y1 - 2019/7

N2 - A barrier to hepatitis C treatment for people who inject drugs (PWID) is needing to attend multiple appointments for diagnosis. Point-of-care hepatitis C tests provide results within 20 to 105 minutes and can be offered opportunistically in nonclinical settings such as needle syringe programmes. In this nested qualitative study, we explored the acceptability of point-of-care testing for PWID. PWID attending participating needle syringe programmes were screened using the OraQuick HCV antibody mouth swab (result in 20 minutes); those with a reactive result then underwent venepuncture for a point-of-care RNA test: the Xpert HCV Viral Load (result in 105 minutes). Convenience sampling was used to select participants for a semi-structured interview. A hybrid thematic analysis was performed, guided by Sekhon's “Theoretical Framework of Acceptability.” Nineteen participants were interviewed. Three core themes emerged: "people and place," "method of specimen collection," and "rapidity of result return." It was highly acceptable to be offered testing at the needle syringeprogrammes by nurses and community health workers, who were described as competent and nonjudgemental. Most participants reported that even if a finger-stick point-of-care RNA test were an option in the future, they would prefer venepuncture, as the sample could be used for pre-treatment workup and bundled testing. Waiting 20 minutes to receive the antibody test result was acceptable, whereas the 105 minutes required for the RNA result was unacceptable. Offering point-of-care hepatitis C testing at needle syringe programmes is acceptable to PWID, however tests that avoid venepuncture are not necessarily the most attractive to PWID.

AB - A barrier to hepatitis C treatment for people who inject drugs (PWID) is needing to attend multiple appointments for diagnosis. Point-of-care hepatitis C tests provide results within 20 to 105 minutes and can be offered opportunistically in nonclinical settings such as needle syringe programmes. In this nested qualitative study, we explored the acceptability of point-of-care testing for PWID. PWID attending participating needle syringe programmes were screened using the OraQuick HCV antibody mouth swab (result in 20 minutes); those with a reactive result then underwent venepuncture for a point-of-care RNA test: the Xpert HCV Viral Load (result in 105 minutes). Convenience sampling was used to select participants for a semi-structured interview. A hybrid thematic analysis was performed, guided by Sekhon's “Theoretical Framework of Acceptability.” Nineteen participants were interviewed. Three core themes emerged: "people and place," "method of specimen collection," and "rapidity of result return." It was highly acceptable to be offered testing at the needle syringeprogrammes by nurses and community health workers, who were described as competent and nonjudgemental. Most participants reported that even if a finger-stick point-of-care RNA test were an option in the future, they would prefer venepuncture, as the sample could be used for pre-treatment workup and bundled testing. Waiting 20 minutes to receive the antibody test result was acceptable, whereas the 105 minutes required for the RNA result was unacceptable. Offering point-of-care hepatitis C testing at needle syringe programmes is acceptable to PWID, however tests that avoid venepuncture are not necessarily the most attractive to PWID.

KW - Community Health Services

KW - hepatitis C

KW - needle-exchange programs

KW - point-of-care systems

KW - substance abuse, intravenous

UR - http://www.scopus.com/inward/record.url?scp=85063684536&partnerID=8YFLogxK

U2 - 10.1111/jvh.13087

DO - 10.1111/jvh.13087

M3 - Article

VL - 26

SP - 919

EP - 922

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

SN - 1352-0504

IS - 7

ER -